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Abstract: Investigation of minor metabolites in the extracts of the red alga Sphaerococcus 
coronopifolius collected from the rocky coasts of Corfu Island in the Ionian Sea yielded 
two new diterpene alcohols, sphaerollanes I,  and II (1,  2) featuring neodolabellane 
skeletons, and the new sphaeroane diterpene alcohol 16-hydroxy-9S*-acetoxy-8-epi-
isosphaerodiene-2 (3), along with two previously reported metabolites 4, 5. The structures 
of the new natural products, as well as their relative stereochemistry, were elucidated on 
the basis of extensive spectral analysis, including 2D-NMR experiments. 
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1. Introduction 
 
All organisms biosynthesize secondary metabolites for certain essential physiological functions and 
exhibit complex chemical profiles, frequently including terpene metabolites. The numerous ways that 
the basic C5 units can be joined together and the different ecological pressures under which organisms 
have evolved justifies the enormous number and the diversity of the elaborated terpenoid   
structures [1]. 
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Sphaerococcus coronopifolius has been the focus of previous chemical investigations, which 
showed the presence of interesting diterpenes with two, three and four ring carbon skeletons, most of 
which contain one or two bromine atoms [2,3]. 
In the course of our ongoing investigations toward the isolation of bioactive metabolites from 
marine organisms of the Greek seas [4,5], we recently studied the chemical composition of the red alga 
S. coronopifolius, collected from the west coast of Corfu Island. In this report we describe the isolation 
and structure elucidation of two new diterpenes 1, 2 with neodolabellane carbon skeletons, and one 
new sphaeroane diterpene 3, along with the already described metabolites presphaerol (4) [6-8] and 
isosphaerodiene-1 (5) [8,9] (Figure 1). The structures of the new metabolites were elucidated by 
extensive spectroscopic analyses and their relative stereochemistry was established by NOESY 
experiments. Moreover, detailed analyses of the 1D- and 2D-NMR spectra allowed full assignment of 
the 
13C- and 
1H- data which had not been previously reported for 4 and 5. 
 
Figure 1. Structures of compounds 1-5. 
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2. Results and Discussion 
 
S. coronopifolius was collected in Palaiokastritsa Bay on the west side of Corfu Island and the 
CH2Cl2/MeOH extract of the freeze-dried alga was subjected to a series of column chromatography 
fractionations on silica gel, as well as normal, reversed and chiral phase high performance liquid 
chromatography (HPLC) separations to yield compounds 1 - 5 in pure form. 
Sphaerollane I (1) was obtained as a colorless viscous oil. The molecular formula, C22H36O3, which 
was derived from HRMS and NMR data (Table 1), requires five degrees of unsaturation. The LRΕI-
MS ions at m/z 330 [M-H2O]
+, at m/z 288 [M-AcOH]
+, and at m/z 270 [M-H2O-AcOH]
+ indicated the 
presence of an acetate and a hydroxyl group. This was supported by the IR spectrum, which contained 
intense ester bands at 1,730 cm
-1 (C=O stretch), 1,240 and 1,030 cm
-1 (C–O stretch), and showed the Mar. Drugs 2009, 7                                                
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presence of hydroxyl functionality (vmax 3,492 cm
-1). Analysis of the NMR data (Table 1) revealed the 
presence of one acetate group (δH 2.06 s; δC 170.8 s, 21.2 q), a disubstituted double bond (δH 5.52 d 
and 5.66 dd; δC 137.3 d and 127.5 d), an olefinic methylene group (δH 4.74 br. t and 4.65 br. s; δC 
149.8 s and 107.0 t), and a tertiary alcohol (δC 73.4 s). Interpretation of the 
1H-
1H COSY,   
1H-
1H TOCSY, HSQC, and HMBC data allowed the remaining two degrees of unsaturation to be 
assigned to a neodolabellane carbon skeleton. The H3-16 signal at δH 1.24 (s) showed HMBC 
correlations to C-10 (δC 38.2), C-11 (δC 73.4), and C-12 (δC 137.3), which placed the methyl on the 
quaternary oxygenated carbon adjacent to the 1,2-disubstituted double bond. Cross peaks in the COSY 
spectrum revealed couplings between H-10α (δH 1.66) and H-9b (δH 1.42), H-10β (δH 1.48) and H-9a 
(δH 1.89), and from both H2-9 to H-8 (δH 5.41). Furthermore, the H-8 methine signal showed HMBC 
correlations to C-9 (δC 28.3), C-10 (δC 38.2), C-7 (δC 149.8), C-17 (δC 107.0), and to the acetate signal 
at δC 170.8, confirming the position of methylene carbons C-9 and C-10 between the acetoxy-bearing 
carbon C-8 and the oxygenated carbon C-11. The correlations from H-5β (δH 1.28) and both H2-17  
(δH 4.74 and 4.65) to C-6 (δC 28.4) required the presence of the exomethylene at C-7. The H3-15 signal 
at δH 0.77 (s) correlated with the C-3 (δC 55.4), C-4 (δC 47.1), C-5 (δC 37.0), and C-14 (δC 59.4) 
signals, allowing it to be placed at the C-4 bridge-head position. Homonuclear coupling between H-13 
(δH 5.66) and H-14 (δH 2.18), and HMBC correlations of both H-1β (δH 1.47) and H-12 (δH 5.52) to  
C-14 (δC 59.4) completed the 11-membered ring by positioning the disubstituted double bond next to 
the ring junction. The correlations from both methyl signs H3-19 and H3-20 at δH 0.83 (d) and 0.95 (d), 
respectively, to C-3 (δC 55.4), C-18 (δC 30.3) clearly positioned the isopropyl group at C-3. The signal 
of H-1α at δH 1.36 (m), belonging to one of the remaining intercoupling methylene groups, showed 
HMBC correlation with carbon C-13 (δC 127.5). Thus, C-1 had to be connected to C-14, and the 
remaining C-2 methylene had to be connected to C-3, forming a cyclopentane ring. 
 
Table 1. NMR data
a of compounds 1 – 2. 
  1  2 
Pos.  δH 
mult, 
J 
NOESY  δC
b 
HMBC 
(C→H) 
δH mult,  J NOESY  δC
b 
HMBC 
(C→H) 
1 
β 1.47 
α 1.36 
m 
m 
14 
13, 15 
27.9 t  2, 3 
β 1.57 
α 1.41 
m 
m 
14 
13, 15 
28.2 t  2β, 3 
2 
a 1.85 
b 1.81 
m 
m 
 27.1  t  1α, 1β, 18 
α 1.87 
β 1.30 
m 
m 
20 
14 
28.1 t  3 
3 1.21 m  15  55.4  d 
1α, 1β, 2a, 15, 
18, 19, 20 
1.29  m  15  57.0 d  15, 19, 20 
4      47.1  s 
1α, 2a, 2b, 3, 
5β, 15 
     47.1  s  14,  15 
5 
α 2.07 
β 1.28 
m 
m 
20 
17b 
37.0 t  3, 15 
β 2.52 
α 2.28 
dd 14.9, 
12.0 
ddq 14.9, 
6.2, 1.2 
8, 14 
6, 19 
36.3 t  14, 15 
6 
α 2.16 
β 1.97 
m 
m 
13, 15 
 
28.4 t  5β, 17a, 17b  5.25 
ddq 12.0, 
6.2, 1.2 
5α, 15, 
17, 19 
127.1 d 
5α, 5β, 8, 
17 
7      149.8  s  5β, 8, 17a        132.8 s  5α, 17 Mar. Drugs 2009, 7                                                
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Table 1. Cont. 
 1   2 
Pos.  δH mult,  J NOESY  δC
b 
HMBC 
(C→H) 
δH mult,  J NOESY  δC
b 
HMBC 
(C→H) 
8 5.41  brd  7.9  10β, 17a  75.7 d 
6β, 9b, 10α, 
10β, 17a, 
17b 
5.86 
dd 9.1, 
1.6 
5β, 12, 
9α, 10β 
73.8 d 
9α, 17, 10α, 
10β 
9 
a 1.89 
b 1.42 
m 
m 
 28.3  t  8,  10α, 10β 
β 1.76 
α 1.51 
m 
m 
 
8, 13 
27.5 t  8, 10α 
10 
α 1.66 
β 1.48 
ddd 
14.5, 
7.9, 1.2 
m 
 
8, 12, 
17a 
38.2 t  8, 9a, 9b, 16
α 1.63 
β 1.49 
m 
m 
 
8, 12 
38.3 t  8, 9α, 16 
11       73.4  s 
9a, 9b, 10α, 
12, 13, 16 
      73.0 s  12, 13, 16 
12 5.52 d  15.3 
10β, 14, 
16 
137.3 d  10α, 13, 16  5.66  d 15.3 
8, 10β, 
14, 16 
137.1 d  10α, 13, 16 
13 5.66 
dd 
15.3, 
10.0 
1α, 6α, 
15 
127.5 d  1α, 12  5.49 
dd 15.3, 
10.4 
1α, 9α, 
15 
129.1 d  12 
14 2.18  m  1β, 12  59.4 d  3, 5β, 15  2.22  m 
1β, 2β, 
5β, 12 
59.7 d  5β, 12, 15 
15 0.77  s 
1α, 3, 
6α, 13 
10.9 q  3, 5β 0.67 s 
1α, 3, 6, 
13 
12.5 q  14 
16 1.24  s  12  30.7  q  10α 1.29 s  12  30.3  q   
17 
a 4.74 
b 4.65 
brt 1.2 
brs 
8, 10β 
5β 
107.0 t  6β, 8  1.61  t 1.2  6  17.6 q  6, 8 
18 1.56 
brhept 
6.6 
  30.3 d  3, 19, 20  1.53  m    31.0 d  19, 20 
19
  0.83  d 6.6    22.5 q  3, 18, 20  0.98  d 6.6  5α, 6  22.6 q  20 
20 0.95 d  6.6  5α  23.5 q  3, 18, 19  0.85  d 6.6  2α 22.8  q  19 
21        170.8 s  8, 22        171.3 s  8, 22 
22  2.06  s    21.2 q    1.99  s    21.3 q   
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The relative stereochemistry shown for 1 (Figure 2) was assigned by interpretation of 
1H-NMR 
coupling constants and NOESY data. The E-geometry of the 12,13-olefin was assigned on the basis of 
a 15.3 Hz coupling constant. The NOE correlations observed between H-1β and H-12 with H-14, as 
well as the correlations between H-1α, H-13 and H3-15, required a trans ring fusion and indicated that 
protons H-1β, H-12 and H-14 were on the same (upper) side of the compound, while H-1α, H-13 and 
H-15 were on the opposite. The stereochemistry at C-3 was deduced by the NOE correlation between 
proton H-3 and methyl protons H3-15. The H-8 signal showed a correlation to the H-10β signal, which 
in turn showed a NOE to the H-12 signal, thereby establishing the stereochemistry at C-8. The 
correlation between H-12 and H3-16 indicated that methyl H3-16 is also on the upper side of the ring, 
resulting in the (3R*,4S*,8S*,11R*,12E,14R*)-geometry proposed for sphaerollane I (1). 
 
Figure 2. Relative configurations and key NOE correlations for compound 1. 
 
Compound 2 proved to have the same molecular formula as 1, C22H36O3, which was derived from 
HRMS and NMR data (Table 1), and is an isomer of 1 that differs only in the location of one of the 
double bonds. The structural type and substitution pattern of 2 was elucidated by means of 1D- and 
2D-NMR correlated spectroscopy including HSQC, HMBC and 
1H-
1H COSY. Sphaerollane II (2) 
contained a Δ
6 trisubstituted double bond instead of the Δ
7,17 olefinic methylene in 1. In the 
1H-NMR 
spectrum (Table 1), both H2-5 signals at δH 2.52 (dd) and 2.28 (ddq) were coupled to the H-6 olefinic 
signal at δH 5.25 (ddq) that along with methylene proton H-5α (δH 2.28) showed long-range couplings 
to the H3-17 methyl sign at δH 1.61 (t). The Z geometry of Δ
6olefinic bond was assigned on the basis of 
NOE correlations between H-6 and H3-17, and between H-5β and H-8. Further analysis of the NOESY 
spectrum revealed that the relative stereochemistry at C-3, C-4, C-8, C-11 and C-14 was the same  
as in 1 (Table 1, Figure 3). 
 
Figure 3. Relative configurations and key NOE correlations for compound 2. 
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(3R*,4S*,8R*,9S*,13R*,14R*)-16-Hydroxy-9-acetoxy-8-epi-isosphaerodiene-2 (3) was isolated as 
a colorless oil. The high-resolution mass measurement established the molecular formula as C22H34O3, 
requiring six unsaturation equivalents. The IR spectrum showed bands that were assigned to ester  
(vmax 1,733, 1,240, 1,024 cm
-1) and hydroxyl (vmax 3,367 cm
-1) functionalities, respectively These 
assignments were supported by the positive LRCI-MS ions at m/z 329 [M+H-H2O]
+, at m/z 287   
[M+H-AcOH]
+, at m/z 269 [M+H-AcOH-H2O]
+, and at m/z 255 [M+H-AcOH-CH2OH]
+ indicating the 
presence of an acetate and a primary hydroxyl group.The presence of five sp
2 carbon atoms in the 
molecule, as deduced from the 
13C-NMR and DEPT spectra (Table 2), being for one carbon-oxygen 
and two carbon-carbon double bonds, indicated compound 3 to be tricyclic. The 
1H- and 
13C-NMR 
spectra (Table 2) contained resonances for one acetate group (δH 1.99 s;  δC 170.8 s, 21.2 q), a 
trisubstituted olefinic bond (δH 5.68 br. dd; δC 133.5 s and 127.4 d), an exomethylene (δH 4.79 br. s, 
2H; δC 149.4 s and 114.1 t), and a primary alcohol (δH 3.99 br. s, 2H; δC 66.8 t). Extensive analyses of 
the 2D-NMR data of 3 including COSY, HSQC and HMBC spectra led to the unambiguous 
assignment of all protons and carbons on the sphaeroane skeleton. The H2-16 oxygenated methylene 
protons at δH 3.99 (br. s) showed heteronuclear long range couplings to C-10 (δC 32.7), C-11   
(δC 133.5), and C-12 (δC 127.4), which confirmed the presence of the primary allylic alcohol at C-11. 
Correlations from H-8 methine (δH 2.74) and both H2-10 (δH 2.59 and 2.04) to C-9 (δC 68.7), as well as 
from H-9 (δH 5.35) to the carbonyl signal at δC 170.8 required the acetyl group to be positioned at C-9. 
The olefinic proton H-12 (δH 5.68) showed HMBC correlations to C-8 (δC 51.3) and C-13 (δC 41.6), 
thus positioning both the double bond and the acetate group next to the 6-membered ring junctions. 
The H2-17 olefinic methylene protons at δH 4.79 (br. s) correlated with C-6 (δC 30.8), C-7 (δC 149.4), 
and C-8 (δC 51.3), had to be placed on C-7. Long range heteronuclear couplings from H2-6 (δH 2.23 
and 2.22) to both C-4 (δC 46.4) and C-5 (δC 38.9), and from H2-5 (δH 1.87 and 1.48) to C-7 (δC 149.4) 
were observed in the HMBC spectrum. The H3-15 methyl signal at δH 0.76 showed correlations to C-3 
(δC 58.0), C-4 (δC 46.4), C-5 (δC 38.9), and C-14 (δC 53.7), and was placed on the quaternary carbon  
C-4. The cycloheptane ring was completed by the HMBC correlation observed between H-8 (δH 2.74) 
and C-14 (δC 53.7). The correlation of both H3-19 and H3-20 (δH 0.82 and 0.92) with C-3 (δC 58.0) and 
C-18 (δC 29.8), required the presence of the isopropyl group at C-3. The correlations observed between 
H-1α (δH 1.25) and C-13 (δC 41.6), and between H-2b (δH 1.28) and C-18 (δC 29.8), confirmed the 
place of methylene carbons C-1 and C-2 in the 5-membered ring. 
 
Table 2. 
 NMR data of compounds 3 – 5. 
  3
a 4
b  5
b 
Pos.  δH mult,  J NOESY  δC
c 
HMBC 
(C→H) 
δH mult,  J  δC
c  δH mult,  J  δC
c 
1 
β 1.72 
α 1.25 
m 
m 
12 
12, 13, 15 
27.8 t  14 
a 1.69 
b 1.38 
m 
m 
27.2 t 
a 1.34 
b 1.09 
m 
m 
26.4 t 
2 
a 1.72 
b 1.28 
m 
m 
19 
19 
26.0 t  3 
a 1.66 
b 1.16 
m 
m 
28.2 t 
a 1.65 
b 1.35 
m 
m 
25.9 t 
3 1.15  m  15  58.0  d 
1α, 2b, 5β, 
15, 19, 20 
1.06  m  59.4 d  0.95  m  58.7 d 
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Table 2. Cont. 
 3  4  5 
Pos.  δH mult,  J NOESY  δC
c 
HMBC 
(C→H) 
δH mult,  J  δC
c  δH mult,  J  δC
c 
4       46.4  s 
1β, 2a, 3, 5α, 
5β, 6α, 6β, 15
   45.3  s     46.4  s 
5 
α 1.87 
β 1.48 
ddd 
13.7, 
7.0, 5.8 
m 
15, 20 
9 
38.9 t  6α, 6β, 14, 15
a 1.50 
b 1.49 
m 
m 
37.8 t 
a 1.85 
b 1.06 
dd 
12.8, 
7.4 
t 12.8 
40.0 t 
6 
α 2.23 
β 2.22 
m 
m 
15, 17 
9 
30.8 t  5α, 5β, 17 
a 1.73 
b 1.36 
m 
m 
37.2 t 
a 2.46 
b 1.72 
m 
m 
30.3 t 
7       149.4  s 
5α, 5β, 6α, 
6β, 17 
   74.4  s     129.0  s
8 2.74 
dd 11.2, 
5.4 
10α, 13, 17  51.3 d 
6α, 6β, 9, 
10β, 12, 17 
1.67  m  48.2 d      135.8 s
9 5.35 
ddd 
11.2, 
8.3, 6.2 
5β, 6β, 
10β, 14 
68.7 d  8, 10α, 10β 
a 1.74 
b 1.49 
m 
m 
22.5 t 
a 1.59 
b 1.11 
ddd 
13.7, 
4.2, 3.7 
dt 13.7, 
7.9 
26.0 t 
10 
β 2.59 
α 2.04 
dd 17.0, 
6.2 
dd 17.0, 
8.3 
9, 16 
8, 16 
32.7 t  8, 12, 16 
a 1.91 
b 1.89 
m 
m 
30.8 t 
a 1.94 
b 1.33 
m 
m 
30.2 t 
11       133.5  s  10α, 10β,  16     132.4  s     133.9  s
12 5.68 
brdd 2.9, 
1.2 
1α, 1β, 13, 
16 
127.4 d 
10α, 10β, 13, 
16 
5.39 dm  3.5  126.8  d 5.42  brs 
124.6 
d 
13 2.28  m 
1α, 8, 12, 
15 
41.6 d 
1α, 8, 9, 12, 
17 
2.45  dm 3.5  36.1 d  2.99  brs  37.3 d 
14 1.65  m  9  53.7  d  5α, 8, 15  1.61  m  50.4 d  1.35  m  53.0 d 
15 0.76  s 
1α, 3, 5α, 
6α, 13, 17 
13.9 q  3, 5β  0.90 s 15.1  q  0.77 s  13.0  q 
16 
a 3.99 
b 3.99 
brs 
brs 
10α, 10β, 
12 
66.8 t  10β,  12  1.67 brs 23.7  q  1.73 brs  24.1  q 
17 
a 4.79 
b 4.79 
brs 
brs 
6α, 8, 15  114.1 t  6α, 6β, 8  1.10  s  29.6 q  1.76  brs  20.7 q 
18  1.53  m    29.8 d  2b, 3, 19, 20  1.51  m  30.9 d  1.49 
dhept 
9.1, 6.6 
30.9 d 
19
  0.82  d 6.6  2a, 2b  22.4 q  18, 20  0.89  d 6.7  22.9 q  0.96  d 6.6  23.5 q 
20 0.92  d  6.6  5α  23.7 q  18, 20  0.98  d 6.7  23.6 q  0.86  d 6.6  23.2 q 
21        170.8  s  9,  22         
22  1.99 s    21.2  q         
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Stereochemical assignment of the chiral centers was facilitated by interpretation of 
1H-NMR and 
NOESY spectra. NOE correlations between H3-15 and H-13 and H-1α required trans fusion between 
the 7-membered and the cyclopentane ring. Furthermore, the correlation between H3-15 and H-3 
positioned both H-3 and H-13 co-facial to methyl H3-15. The strong NOEs observed between the pairs 
of protons H-9, H-14 and H-8, H-13 suggested the unusual for a sphaeroane skeleton cis-fusion of the 
7-membered and the cyclohexene rings. Both C-8 and C-13 were assigned as R*, based on the NOE 
correlations of H3-15 with H2-17, of H2-17 with H-8, of the latter with H-10α, and of H3-15 with H-13, 
H-5α and H-6α. Moreover, the NOEs observed between H-14 and H-9, and between H-9 and H-5β, H-
6β and H-10β, secured the relative stereochemistry at chiral centers C-9 and C-14, thereby defining the 
structure as (3R*,4S*,8R*,9S*,13R*,14R*)-16-hydroxy-9-acetoxy-8-epi-isosphaerodiene-2 (3)  
(Figure 4). 
 
Figure 4. Relative configurations and key NOE correlations for compound 3. 
 
 
Along with the above described metabolites two previously reported compounds, presphaerol (4) 
[6-8] and isosphaerodiene-1 (5) [8, 9], were isolated and spectroscopically characterized. Complete 
1H- 
and 
13C-NMR assignments, based on extensive analyses of their 2D-NMR spectra, are now provided 
for the first time for 4 and 5. The co-occurrence of compounds 1, 2 and 3 with the previously described 
4 and 5 in the same organism indicated the possibility that they all derive from a common precursor 
neodolabellane cation [10], as illustrated in the proposed biogenetic pathway (Scheme 1). Thus, 
successive nucleophilic substitution of a H2O molecule, oxidation of the trisubstituted olefinic bond 
[11], and acetylation can yield the neodolabellanes 1 and 2. Alternatively, nucleophilic attack of a H2O 
molecule on the trisubstituted Δ
7 double bond can produce presphaerol (4) [10], which through water 
elimination generates isosphaerodiene-1 (5). Metabolite 3 can be derived from 5 by oxidation of Δ
7 
double bond and successive eliminations, additions of H2O molecules, and a final acetylation. 
Diterpenes of the neodolabellane class have previously been isolated only from soft corals of the 
genera  Cespitularia,  Clavularia, and Lobophytum of the Indian and Pacific Ocean [12-16], while 
diterpenes of the sphaeroane skeleton have been isolated, only from the red alga S. coronopifolius and 
the macromycete Mycena tintinnabulum [17]. 
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Scheme 1. Proposed biogenetic origin of 1-5. 
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3. Experimental Section 
 
3.1. General Experimental Procedures 
 
Optical rotations were measured on a Perkin-Elmer model 341 polarimeter with a 10 cm cell. UV 
spectra were acquired in spectroscopic grade CHCl3 on a Shimadzu UV-160A spectrophotometer. IR 
spectra were obtained using a Paragon 500 Perkin-Elmer spectrophotometer. NMR spectra were 
recorded using a Bruker AC 200 and Bruker DRX 400 spectrometers. Chemical shifts are given on a  
δ (ppm) scale using TMS as internal standard. The 2D-NMR experiments (
1H-
1H COSY, HSQC, 
HMBC, NOESY) were performed using standard Bruker microprograms. The structures in Figures 2, 
3 and 4 were generated and optimised (energy: 43.50, 38.24 and 37.77 Kcal/mole, respectively) by 
“HyperChem™ 7.0” molecular modelling and simulation software (force field: MM+; optimisation Mar. Drugs 2009, 7                                                
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algorithm: Polak-Ribiere). High-Resolution mass spectral data were provided by the University of 
Notre Dame, Department of Chemistry and Biochemistry, Indiana, USA. Low-Resolution Electron 
Impact or Chemical Ionisation MS data were recorded on a Thermo DSQ Mass Detector using Direct 
Exposure Probe (DEP) and methane as the CI gas. Vacuum Liquid Chromatography (VLC) separation 
was performed with Kieselgel 60 (Merck), gravity column chromatography (GCC) was performed 
with Kieselgel 60H (Merck), thin layer chromatography (TLC) was performed with Kieselgel 60 F254 
aluminum support plates (Merck) and spots were detected after spraying with 15% H2SO4 in MeOH 
and charring. HPLC separations were conducted using an Agilent 1100 system equipped with 
refractive index detector and a SupelcoSil 5μ (250×10 mm) HPLC normal phase column or a Kromasil 
100 C18 5μ (250×8 mm) HPLC reversed phase column or a Chiralcel OD 5μ (250×4.6 mm) analytical 
chiral column. 
 
3.2. Plant Material 
 
S. coronopifolius was collected by SCUBA diving in Palaiokastritsa Bay at the west coast of Corfu 
island, Greece, at a depth of 10-15 m in May of 2002. A specimen is kept at the Herbarium of the 
Laboratory of Pharmacognosy and Chemistry of Natural Products, University of Athens 
(ATPH/MO/201). 
 
3.3. Extraction and Isolation 
 
S. coronopifolius was initially freeze-dried (291.4 g dry weight) and then exhaustively extracted 
with mixtures of CH2Cl2/MeOH (3/1) at room temperature. The combined extracts were concentrated 
to give a dark green residue (8.20 g), which was later subjected to vacuum liquid chromatography on 
silica gel, using a 10% step gradient of cyclohexane-EtOAc elution sequence. Fraction F2 (4.01 g), 
eluted with 20% EtOAc in cyclohexane, was fractionated by gravity column chromatography, using a 
2% step gradient of cyclohexane-EtOAc. Fraction F2.8 (524.5 mg), eluted with 8% EtOAc in 
cyclohexane, was further separated by silica gel GCC using isocratic 5% EtOAc in cyclohexane. 
Fraction F2.8.15 (53.3 mg) was subjected repeatedly to reverse phase HPLC using MeOH as mobile 
phase to afford pure 4 (1.9 mg) and 5 (1.8 mg). The CH3CN soluble portion (173.4 mg) of fraction 
F2.11 (50% EtOAc in cyclohexane) (199.6 mg) was subjected to reverse phase HPLC, using CH3CN 
as mobile phase. Peak F2.11.7 (retention time 17.9 min) (12.4 mg) was further purified by normal 
phase HPLC with 20% n-hexane in CHCl3. Compounds 1 (4.9 mg) and 2 (0.9 mg) were isolated by 
chiral HPLC with 0.5% i-PrOH in n-hexane as eluent, from peak F2.11.7.2 (retention time 9.0 min) 
(5.8 mg). The CH3CN soluble portion (323.4 mg) of fraction F5 (70% EtOAc in cyclohexane)   
(446.6 mg) was subjected to reverse phase HPLC, using CH3CN as mobile phase. Peak F5.12 
(retention time 11.6 min) (51.6 mg) was further separated by normal HPLC with 30% n-hexane in 
CHCl3 to yield pure 3 (4.4 mg). 
 
Sphaerollane-I (1). Colorless oil; [α]D +81.8 (c 2.90, CHCl3); UV (CHCl3) λmax (log ε) 255 (0.72) nm; 
IR (CHCl3) νmax 3,492, 1,730, 1,240, 1,030, 970, 896 cm
-1; NMR data (CDCl3), see Table 1; EIMS  
70 eV, m/z (rel. int. %) 330 [M-H2O]
+ (3), 306 [M-CH2CO]
+ (29), 288 [M-AcOH]
+ (37), 270 [M-Mar. Drugs 2009, 7                                                
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AcOH-H2O]
+ (44), 255 [M-AcOH-H2O-Me]
+ (20), 245 [M-AcOH-iPr]
+ (72), 227 [M-AcOH-H2O-
iPr]
+ (71), 199 (17), 171 (31), 133 (45), 91 (69), 43 [CH3CO]
+ (100); HRFAB-MS (m/z): 349.2732 
[M+H]
+ (calcd for C22H37O3, 349.2743). 
 
Sphaerollane-II (2). Colorless oil; [α]D +5.5 (c 1.10, CHCl3); UV (CHCl3) λmax (log ε) 250 (1.76) nm; 
IR (CHCl3) νmax 3,422, 1,728, 1,240, 1,014, 973 cm
-1; NMR data (CDCl3), see Table 1; CIMS m/z (rel. 
int. %) 331 [M+H-H2O]
+ (1), 289 [M+H-AcOH]
+ (11), 271 [M+H-AcOH-H2O]
+ (38), 255 [M+H-
AcOH-H2O-Me]
+ (9), 245 [M+H-AcOH-iPrH]
+ (14), 227 [M+H-AcOH-H2O-iPrH]
+ (8), 173 (14),   
147 (9), 119 (11), 105 (8), 60 [AcOH]
+ (100); HRFAB-MS (m/z): 348.2674 [M]
+ (calcd for C22H36O3, 
348.2664). 
 
16-Hydroxy-9S*-acetoxy-8-epi-sphaerodiene-2 ( 3).  Colorless oil; [α]D +10.3 (c 2.90, CHCl3); UV 
(CHCl3) λmax (log ε) 244 (1.95) nm; IR (CHCl3) νmax 3,367, 1,733, 1,240, 1,024, 888 cm
-1; NMR data 
(CDCl3), see Table 2; CIMS m/z (rel. int. %) 347 [M+H]
+ (1), 329 [M+H-H2O]
+ (9), 287 [M+H-
AcOH]
+ (29), 269 [M+H-AcOH-H2O]
+ (100), 255 [M+H-AcOH-CH2OH]
+ (11), 243 [M+H-AcOH-
iPrH]
+ (8), 225 [M+H-AcOH-H2O-iPrH]
+ (12), 213 [M+H-AcOH-CH2OH-iPr]
+ (7), 171 (14),   
145 (13), 137 (16), 105 (13), 60 [AcOH]
+ (38); HRFAB-MS (m/z): 347.2586 [M+H]
+ (calcd for 
C22H35O3, 347.2589). 
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